EGFR and non-small cell lung carcinoma: Tian et al. found that EP2 methylation is associated with a better prognosis of non-small cell lung cancer, and EP2 methylation is present with greater frequency in tumors with epidermal growth factor receptor (EGFR) mutation than in non-EGFR mutated tumors41.